NCT02758652View on ClinicalTrials.gov

Molecular Mechanisms Leading to Chemoresistance in Epithelial Ovarian Cancer

Active, not recruitingOBSERVATIONAL
Enrollment

160

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

April 30, 2026

Study Completion Date

May 31, 2026

Conditions
Ovarian Cancer
Trial Locations (1)

33521

Tampere University Hospital, Tampere

All Listed Sponsors
collaborator

Tampere University

OTHER

collaborator

University of Helsinki

OTHER

lead

Tampere University Hospital

OTHER

NCT02758652 - Molecular Mechanisms Leading to Chemoresistance in Epithelial Ovarian Cancer | Biotech Hunter | Biotech Hunter